Leukocyte-Adherence Inhibition: A Specific Assay of Cell-Mediated Immunity Dependent on Lymphokine-Mediated Collaboration between T Lymphocytes
Open Access
- 1 June 1978
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 120 (6) , 1957-1966
- https://doi.org/10.4049/jimmunol.120.6.1957
Abstract
The leukocyte-adherence inhibition (LAI) assay was studied to determine its immunologic relevance and identify the cell populations on which it depends. Two systems were employed: peripheral blood leukocytes from humans immunized with KLH, and lymph node cells from rats immunized with DNP-BGG. In both cases, LAI responses appeared about 3 to 4 days after immunization, reached a peak about 3 to 4 weeks later, and diminished thereafter. Reimmunization resulted in a booster-like response. LAI analysis in both systems showed dose-response dependency. Responses could be elicited only with the immunizing antigen. Virtual depletion of phagocytic cells had no effect on the response. E-rosette-forming cells gave an excellent response to KLH and also produced an active supernatant (lymphokine). Cells not forming spontaneous E-rosettes were inactive and could not produce active supernatants. Only those nonimmune cells that formed E-rosettes could respond to active supernatants. Thus, the LAI response is a specific indicator of cell-mediated immunity. T lymphocytes probably are required both at the antigen-reactive stage and at the stage of responding to the T cell-dependent lymphokine.This publication has 6 references indexed in Scilit:
- Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assayInternational Journal of Cancer, 1976
- Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti‐tumour immunity. III. “Blockade” of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patientsInternational Journal of Cancer, 1976
- Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibodyInternational Journal of Cancer, 1976
- Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. I. Monocyte is the reactive cellInternational Journal of Cancer, 1976
- Capillary tube leukocyte adherence inhibition: An assay for cell-mediated immunity in cancer patientsInternational Journal of Cancer, 1976
- Brief Report: Simplified Myeloperoxidase Stain Using Benzidine DihydrochlorideBlood, 1965